[Drug-induced liver diseases].
D000082:Acetaminophen / Q000009:adverse effects; D000328:Adult; D000437:Alcoholism / Q000150:complications; D001379:Azathioprine / Q000009:adverse effects; D001663:Bilirubin / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury; D002746:Chlorpromazine / Q000009:adverse effects; D002779:Cholestasis / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000031:analogs & derivatives; D004790:Enzyme Induction; D005234:Fatty Liver / Q000209:etiology; D005260:Female; D006099:Granuloma / Q000139:chemically induced; D006221:Halothane / Q000009:adverse effects; D006529:Hepatomegaly / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010114:Oxyphenisatin Acetate / Q000009:adverse effects; D011247:Pregnancy; D013449:Sulfonamides / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects
D013449:Sulfonamides; D000082:Acetaminophen; D004295:Dihydroxyphenylalanine; D013752:Tetracycline; D001379:Azathioprine; D001663:Bilirubin; D010114:Oxyphenisatin Acetate; D002746:Chlorpromazine; D006221:Halothane
Medikamentöse Leberschäden